Multiple Manufacturers

ANDEXXA

Manufacturer:

Multiple Manufacturers

Andexxa HCPCS:

J7169

HCPCS Code Descriptor:

Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg

Category:

J Code

Andexxa NDCs:

00310-3200-04, 00310-3200-05, 69853-0102-01

Primary Type:

Hematology

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00310-3200-04, 00310-3200-05, 69853-0102-01

About Andexxa:

ANDEXXA is a medication manufactured by multiple manufacturers and aligned to the J Code: J7169. ANDEXXA is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J7169 Added Date:

July 1, 2020

J7169 Effective Date:

July 1, 2020

J7169 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Andexxa billing and coding information.
Andexxa patient assistance information can be found through AstraZeneca Access 360 at the URL: https://www.myaccess360.com/home.html
Our team is still working to identify a prescribing information source for ANDEXXA
Our team has not yet identified a source of side effects information for ANDEXXA. Please check back in a few weeks.